Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ICELAND”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 289 records · Page 16Linked to original sources
PubMed2000

[Health-related quality of life among Icelanders.].

OBJECTIVE: To study health-related quality of life (HRQL) among adults in Iceland with a generic Icelandic instrument, IQL (Icelandic Quality of Life), if it is the same among men and women, and if it changes by increasing age. Furthermore, it was intended to find norms for men and women in different age groups in order to evaluate patients' deviation in HRQL. MATERIAL AND METHODS: IQL was sent to 2800 individuals, a random sample from the national registry, stratified by sex in 10 years age groups from 20-79 years and those above 80 years. For each sub-scale on the instrument and for the combined instrument raw scores were calculated for men and women in the age groups 20-49 years, 50-69 years and 70 years and older which were converted to a T-score. RESULTS: The response rate was 61%, lower among the youngest (20-29 years) as well as among the oldest (80 years and older), but similar for men and women. Internal missing values were few. Reliability of the test was good (Cronbach's alfa=0.91). HRQL among women in general was worse than that of men both in general as well as on most sub-scales. HRQL decreases with advancing age, however, with certain exceptions. A marked difference was found between the youngest and the oldest. The quality of life in the oldest group is worse than among the younger, both in general and on most sub-scales except finance and anxiety. Depression and social function do not change significantly with age. The oldest are especially worse on the scales general health, energy and physical health. Sleep becomes worse with increasing age, especially among women. Five factors explain two thirds of the variance, general health (23.4%), mental wellbeing (20.5%), satisfaction (9.0%), sleep (6.9%) and finance (6.3%). CONCLUSIONS: When evaluating HRQL among patients it is necessary for health-care providers and researchers to take into consideration the difference in HRQL between men and women and the changes occurring with age.

English Abstract↗
PubMed2000

[Validation of an Icelandic version of the Geriatric Depression Scale (GDS).].

OBJECTIVE: The GDS is a widely used tool world wide, both in clinical practice and in research of the elderly. The objective was to translate and validate the Geriatric Depression Scale (GDS) in Iceland. The short version of the GDS was also studied. MATERIAL AND METHODS: GDS was translated from English to Icelandic and backtranslated. Individuals, both hospitalised and healthy, born 1933 or before were included in the study. Those who had MMSE (Mini Mental State Examination) score under 23 were excluded. Seventy-one individuals were examined for depression both with a structured interview, Composite International Diagnostic Interview; 1993 (CIDI-a) and with the GDS. RESULTS: The GDS results were comparable to the results from the interview. The cutoff score for depression was chosen 13/14 according to the most favorable values of sensitivity (0.77), specificity (0.95), positive predictive value (0.77) and kappa (0.72). One cutoff was chosen because in our study there were persons with moderate or severe depression but no one with mild depression was detected. Our cutoff score for depression was identical with the cutoff score in the original american GDS version, but the original american version included a cutoff for mild depression also. CONCLUSIONS: The Icelandic GDS is a reliable method to screen for depression among the elderly. We conclude that GDS is an useful tool in unravelling depressive illness amongst the elderly although not diagnostic per se.

English Abstract↗
PubMed2000

[Allergy and intolerance to food in an Icelandic urban population 20-44 years of age.].

OBJECTIVE: Symptoms related to the intake of certain food items are common. In most of these cases food allergy/intolerance can not be confirmed. In the Icelandic part of the European Community Respiratory Health Survey the prevalence of food-related symptoms was assessed among adult Icelanders. MATERIAL AND METHODS: Three thousand and six hundred men and women, 20-44 years, were studied, among them 800 were randomly chosen for a more detailed investigation. Additionally, all those using asthma medication or having asthma symptoms were investigated. A questionnaire inquired about chest symptoms, symptoms related to food-intake and eating habits. In Iceland additional questions were asked concerning drug intolerance, urticaria, Quincke oedema, childhood eczema, migraine and psoriasis. All subjects underwent skin prick tests against 12 common allergens, spirometry and methacholine challenge. Specific IgE antibodies against five airborne allergens and six common food allergens were measured. RESULTS: Among subjects with food-related symptoms, 68% reported complaints from the GI-tract, 22% had skin rash or pruritus, 15% severe headache, 11% breathlessness, 8% a running/stuffy nose and 4% fatique. Altogether 42 food items were considered likely causes of the reported symptoms. Twenty-two percent of the random sample had symptoms related to the intake of a particular food and 15% reported always having the same symptom after intake of this food. Women reported food-related symptoms somewhat more often that men (17% and 13% respectively (p=0.21)). In the random sample only 1.8% had antibodies to one or more of the foods measured. There was a significant relationship between food-related symptoms and reported migraine, urticaria and Quincke oedema and a particularily strong relationship with drug intolerance. Migraine, urticaria, Quincke oedema and drug intolerance were significantly more common among women (p<0.0001, p<0.01, p<0.05 and <0.002 respectively). No relationship was seen between food-related symptoms and positive methacholine tests. CONCLUSIONS: In conclusion this study reveales a large group of subjects reporting food-releated symptoms. This group also reported a big prevalence of unrelated symptoms such as drug intolerance and migraine. Type-1 allergy is unlikely to be the cause to more than a small part of these symptoms.

English Abstract↗
PubMed2001

[Home mechanical ventilation in Iceland.].

OBJECTIVE: To describe the users of home mechanical ventilation treatment in Iceland. MATERIAL AND METHODS: Records for all patients in Iceland using noninvasive ventilatory support at home on April 30th 1999 were analysed. RESULTS: A total of 54 patients were using ventilatory support at home. There were 33 males and 21 females. The mean age for the group was 61 years. The mean treatment time was 3.5 years. The majority were using pressure controlled ventilators that were connected to a nose mask or full face mask. The most common reason for treatment was decreased respiratory muscle function. In 11 patients this was secondary to muscle- or neurological diseases, in nine from TBC sequelae and in six post polio or from idiopathic kyphoscoliosis. In addition there were 21 patients that had a combination of chronic obstructive pulmonary disease and sleep-related breathing disorder. Cheyne-Stoke breathing secondary to congestive heart failure was the reason for home ventilatory treatment in five males and two females. These patients had relatively normal spirometric and bloodgas results, which is in contrast to the rest of the group, where spirometric values were on the average less than 50% of predicted. Arterial blood gases commonly showed hypoxia and 16 of the patients had long-term oxygen therapy (over 16 hrs/day). CONCLUSIONS: Home ventilatory treatment has become part of medical treatment in Iceland and benefits patients with decreased ventilatory function, especially during sleep.

English Abstract↗
PubMed2001

[Hirschprung' disease in Iceland 1969-1998.].

INTRODUCTION: Hirschprung s disease (HD) is a congenital disease characterized by the absence of myenteric and submucosal ganglion cells in the distal alimentary tract and results in decreased motility in the affected bowel segment. The purpose of this study was to review the incidence, presentation, treatment and operative results in children with Hirschprung's disease in Iceland. MATERIAL AND METHODS: Thirteen infants with Hirschprung s disease (11 boys and two girls) were treated in Landspítalinn University Hospital between January 1969 and December 1998. The records of these patients were reviewed retrospectively. RESULTS: The incidence of Hirschprung's disease in Iceland is 1/10,000 and 85% of those are boys. All the infants were born full term. No family history and no associated abnormalities were noted. The mean age at first admission was 20 (1-136) days and mean age at diagnosis was 166 (5-623) days. Swenson's pull-through (two- or three-stage procedure) was carried out in all patients at the mean age of 18.6 months. The extent of aganglionosis was rectosigmoid colon in 10 patients (77%) and one patient had total colonic aganglionosis. Postoperative complications occurred in seven patients (53%), adhesion ileus being the most common complication. Long term bowel function was satisfactory in 85% of the patients. CONCLUSIONS: The incidence of Hirschprung's disease in Iceland is low. Mean age at diagnosis is six months. Sixty percent of the children are discharged with a wrong diagnosis after first admission to hospital and this could be improved by diagnosing the disease at an earlier stage. Postoperative complications are common but no deaths occurred. Bowel function following definitive correction is good compared to other studies.

English Abstract↗
PubMed1996

High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.

Studies on Icelandic breast cancer families have shown that most of them segregate a 999del5 BRCA2 mutation. Here, we report the frequency of the 999del5 BRCA2 mutation in an Icelandic control population and four different groups of cancer patients diagnosed with (a) breast cancer; (b) ovarian cancer; (c) prostate cancer (patients younger than 65 years); and (d) other cancer types. The proportions of individuals carrying the mutation were 0.4% in the control population and in the patient groups 8.5%, 7.9%, 2.7%, and 1.0%, respectively. Our results indicate that BRCA2 confers a very high risk of breast cancer and is responsible for a substantial fraction of breast and ovarian cancer in Iceland, but only a small proportion of other cancers.

Adult↗
PubMed1999

The assent of a nation: genethics and Iceland.

The Icelandic parliament passed legislation authorizing the establishment of a national health sector database which will be sponsored financially by private enterprises through DeCode Genetics Inc. Health related data will be gathered from patients, without their informed consent, from all points of contact with Icelandic public and private health care providers. A centralized data curator will 'non-personalize' the identity of the subjects in a one-way coding system which the government and DeCode Genetics argue overrides the need for informed consent. This legislation is in conflict with the European Data Protection Act, which requires informed consent for the collection of personal data. The law raises many ethical questions regarding the central tenets of informed consent, the power of government, the rights of the human subject, and finally, the responsibility of the clinician balancing commitments of the patient and research.

Bioethics↗
PubMed1997

Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967-1991--the Reykjavik Study.

This is the first large survey carried out in Iceland to estimate the prevalence and incidence of known and unknown non-insulin-dependent (Type 2) diabetes (NIDDM) among males and females, aged 34-79. The population in this survey was 9128 males and 9759 females born between 1907 and 1935 and examined in the prospective Reykjavik Study 1967-1991. Participants were invited from one to five times during the 24 years. The overall age-standardized prevalence (95% confidence limits) was 2.9% (2.5 to 3.3) for males and 2.1% (1.8 to 2.5) for females, aged 30-79, according to the European standard population. The overall annual age-standardized incidence rate per 100,000 was 377 (303 to 457) for males and 266 (212 to 320) for females, aged 35-74, standardized to the European population. Our study indicates that the prevalence of NIDDM is relatively low compared to other Nordic and western countries, and has not been increasing over the past 20 years. Furthermore, the incidence of NIDDM has not been changing during the past 20 years of follow-up among Icelandic males and females aged 34-79.

Administration, Oral↗
PubMed1998

Six-month prevalence of phobic symptoms in Iceland: an epidemiological postal survey.

An epidemiological questionnaire survey of the prevalence of the various types of phobias was undertaken among the Icelandic population. Out of 1,000 individuals surveyed, in accord with national census data held in Reykjavík, 775 questionnaires were returned. Results confirmed that among Icelanders, phobic symptoms overall are more prevalent among women than men. Prevalence rates were lower for individuals 45 years or older, suggesting that extinction may occur with ageing. Divorced or separated individuals were most at risk, as were women homemakers, disabled, or unemployed persons. Education was inversely related to the incidence of all types of phobias, with individuals with less than 10 years of education reporting the highest rates of phobia. Most respondents attributed the onset of their phobias to a specific terrifying experience, and in many cases, to observing another person displaying an intense fear reaction in a given situation. Factor analysis of the data indicated that social anxiety phobias accounted for the greatest proportion of variance.

Adolescent↗
PubMed2000

Genetic epidemiology of breast cancer: segregation analysis of 389 Icelandic pedigrees.

A genetic epidemiologic investigation of breast cancer involving 389 breast cancer pedigrees including information on 14,721 individuals from the Icelandic population-based cancer registry is presented. Probands were women born in or after 1920 and reported to have breast cancer in the cancer registry. The average age of the 389 probands was 45.5 years (SD 8.92). Segregation analyses was performed evaluating residual maternal effects, a dichotomous cohort effect, and assuming the age at diagnosis followed a logistic distribution after log-transformation. Familial aggregation could be best explained by the inheritance of a high-risk allele leading to early onset breast cancer among the homozygotes, which represent approximately 2.6% of the population. A Mendelian codominant model was selected as the best fitting model, with an estimated age at diagnosis of 51.8 years among these high-risk homozygotes, 64.0 years for heterozygotes and 76.3 years for the low-risk genotype. The predicted cumulative risk for homozygote carriers of the high-risk allele is 32.2% by age 60, compared to 16.4% for heterozygotes and 5.0% for non-carriers of the same age. These predicted age profiles in the current study complement recent reports from Iceland of a majority of BRCA2 mutation carriers being diagnosed with breast cancer below the age of 50 years, and 60 years being the mean age at diagnosis for non-carriers. This model also predicted a high background risk of breast cancer for women in this population (estimated susceptibility gamma = 0.44 +/- 0.08). This implies that if carriers and non-carriers did not die of competing causes, the estimated risk of being diagnosed with breast cancer by age 80 years irrespective of carrier status is 11.4%.

Age of Onset↗
PubMed1999

Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families.

OBJECTIVE: To evaluate the production of interleukin-10 (IL-10) as well as levels of IgG and antinuclear antibodies (ANA) in systemic lupus erythematosus (SLE) patients and their first-degree relatives and spouses in Icelandic SLE multicase families. METHODS: IL-10 production was studied by enzyme-linked immunospot assay of freshly isolated peripheral blood mononuclear cells. Total IgG and ANA were also investigated. Subjects consisted of 23 SLE patients and 47 of their first-degree relatives in 9 Icelandic multicase families. Subjects were ethnically matched by a group of healthy controls. A separate study investigated 12 SLE patients (also from SLE multicase families) and their spouses and a matched group of healthy controls. A predefined protocol was used to obtain both clinical and laboratory data, including information about SLE and other autoimmune disorders. RESULTS: The SLE patients had a significantly higher number of IL-10-producing cells compared with both first-degree relatives and healthy controls (P = 0.0005 and P < 0.0001, respectively). First-degree relatives also had a significantly higher number of IL-10-producing cells compared with healthy controls (P = 0.01). This was also true for the spouses of SLE patients, who had a higher number of IL-10-producing cells compared with matched healthy controls (P = 0.02). CONCLUSION: SLE patients and their first-degree relatives, as well as a limited number of healthy spouses of SLE patients, had increased numbers of spontaneous IL-10-producing cells. These data support the hypothesis that IL-10 production may be genetically determined, and may predispose one toward development of SLE. This has previously been suggested by studies of SLE patients and their relatives in another ethnic population, using another method for measuring IL-10 production. Although these data are based on a small number of observations, they suggest that not only genetic but also environmental factors may be of importance in determining IL-10 production, since the spouses of SLE patients also had an increased number of IL-10-producing cells.

Autoantibodies↗
PubMed1995

Cancer incidence among seamen in Iceland.

The cancer incidence was investigated among 27,884 fishermen and sailors from the merchant fleet who had been members of a pension fund for seamen during 1958-1986 in Iceland. The cancer incidence was followed through 1966-1988. Expected values were based on rates for the general male population in Iceland. In the whole cohort, 758 malignant neoplasms had occurred as compared to 688.43 expected, standardized incidence ratio (SIR) = 1.10, 95% confidence limit (CI) 1.03-1.18. There was an excess for cancer of the stomach, rectum, larynx, and lung and nonmelanoma skin cancer; the SIRs were 1.29, 1.44, 1.77, 1.61, and 1.51, respectively. When analyzing the cancer incidence according to length of employment, the SIRs for many of the cancer sites were high for those with a short employment and many SIRs decreased with increasing length of employment. The SIRs for lung cancer were high in all subgroups. Only for stomach cancer and leukemia was there a substantial increase in SIR with increasing length of employment. The SIR was 1.55 for stomach cancer (CI 1.01-2.27) in the group with longer than 10 years of employment, and 1.97 for leukemia (CI 0.85-3.87) in the same group. It is concluded that the risk of both stomach and lung cancer seems to be associated with the occupation of seamen.

Cohort Studies↗
PubMed1978

Age at menarche in Iceland.

The purpose of this study was to elucidate the mean age at menarche in Icelandic girls and compare it with results from other Scandinavian populations as well as in other ethnic groups. The study was performed during the school year 1972-1973 on a cross-sectional sample of 682 girls (aged 8.5 to over 17 years), constituting 9.5% of the girls from the third to eleventh forms in all the primary and secondary schools of Reykjavik. The mean age at menarche in Iceland, elicited by the status quo method, proved to be 13.06 +/- 0.10 years (S.D. 1.17 years). According to the information given by the girls (recall method), the earliest time of menstruation was 9.83 years and the latest 15.17 years, at which age all but one of the girls were menstruating.

Adolescent↗
PubMed1981

Torus mandibularis among Icelanders.

Nine hundred and seventy-six Icelandic schoolchildren (489 male and 487 female) were surveyed for occurrence of torus mandibularis. No sexual dimorphism was observed but there was a statistically significant difference between areas. A highly significant positive association between age and frequency of occurrence and size was also observed. Single tori were more prevalent than multiple ones and also appeared earlier. Symmetrical occurrence predominated, but when unilateral, tori were more often found on the right side. Secular changes in the incidence of torus mandibularis among Icelanders suggest the strong influence of environmental factors.

Adolescent↗
PubMed1985

Torus palatinus in Icelandic schoolchildren.

Three populations in South- and North-Thingeyjarsýslas, Northeast Iceland, were surveyed for the presence of torus palatinus. A total of 987 schoolchildren (489 male and 487 female) were examined. A statistically significant difference was noted between the prevalence in South-Thingeyjarsýsla (33.3%) and North-Thingeyjarsýsla (14.6%). Prevalence and size were affected by age and population but not by sex. An association between torus palatinus and torus mandibularis was not found. Secular changes in the occurrence of torus palatinus in Icelanders emphasize the importance of environmental etiological factors and diminish the value of torus palatinus as a racial trait.

Adolescent↗
PubMed1994

Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis.

OBJECTIVE: To investigate the incidence and clinical and histopathologic features of giant cell (temporal) arteritis (GCA) in the Caucasian population of Iceland. METHODS: All patients diagnosed between 1984 and 1990 were included. Case ascertainment for the study was done in 2 ways: 1) a computerized search from all hospitals and primary care clinics for the diagnosis of GCA, and 2) a review of all temporal artery biopsies performed during the 7-year period. RESULTS: One hundred thirty-three patients with GCA were identified. All fulfilled the 1990 American College of Rheumatology criteria for the classification of GCA. The incidence rate for the population 50 years and older was 27/100,000 (36/100,000 and 18/100,000 for women and men, respectively). Clinical findings included the following: mean age at diagnosis 72.5 years for women and 70.3 years for men, new headache 63.2%, abnormal temporal artery on palpation 43.6%, mean erythrocyte sedimentation rate 88 mm/hour, symptoms of polymyalgia rheumatica 48.1%, and visual disturbances 14.3%. A total of 744 patients underwent temporal artery biopsy during the 7-year period; 16.8% had a positive biopsy result. All 133 patients with the diagnosis of GCA underwent a temporal artery biopsy; 94% had a positive result. Histopathologic findings from the positive biopsies included a fragmented internal elastic lamina in 99.2%, giant cells in 65.6%, and fibrinoid necrosis in 12%. CONCLUSION: Compared with previous epidemiologic surveys, this study shows a high incidence of biopsy-proven GCA in Iceland.

Aged↗
PubMed2002

Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.

Breast cancer and prostate cancer are the most commonly occurring cancers in females and males, respectively. The objective of this project was to test the hypothesis that breast cancer in females and prostate cancer in males represent homologous cancers that may be controlled by one or more common unidentified genes that may explain some of the observed familial aggregation. We modeled the transmission of a breast-prostate cancer phenotype in 389 pedigrees ascertained through a breast cancer proband drawn from the Icelandic Cancer Registry. Assuming that age at diagnosis of this combined phenotype followed a logistic distribution, segregation analyses were performed to evaluate residual parental effects, a sibship covariate, and a dichotomous cohort effect. The most parsimonious model was a Mendelian codominant model, which could partly explain the familial aggregation of both cancers. Inheritance of a putative high-risk allele (A) predicted gender-specific mean ages of onset for females as 53.8 years, 59.7 years, and 65.6 years for the putative AA, AB, and BB genotypes, respectively. Similarly, the predicted means were 73.7 years, 75.6 years, and 78.3 years, respectively, among males. Under this codominant model, the lifetime risk of a woman being affected was 19% by age 80 years. This implies that when prostate cancer among male relatives of breast cancer probands (unselected for family history or early-onset disease) is considered a pleiotrophic effect of the same gene that increases the risk for breast cancer, women are predicted to have a less than 1 in 5 risk of developing breast cancer when they carry the putative high-risk allele. However, this is a higher risk than in the general Icelandic population. Our results suggest that BRCA2 mutations alone are inadequate to explain all of the excess clustering of prostate cancer cases in families of breast cancer probands, and that additional genes conferring excess risk to both breast and prostate cancer may exist in this population.

Aged↗
PubMed1978

The effect of mass screening in Iceland, 1965-74, on the incidence and mortality of cervical carcinoma.

A clinic for early detection of cancer of the uterine cervix has been in operation in Iceland since 1964, aimed until recently at the age-group 25-59. More than 85% of women in this age group have been screened at least once. Mortality from cancer of the cervix had been rising in Iceland, and continued to rise during the first few years of operation of the screening clinic. Since 1970, however, a more than two-fold reduction in mortality has been observed among women aged 25-59. There has been a similar decrease in incidence of tumours of stages II, III and IV. Both deaths and advanced tumours are largely confined to women who have never been screened. Alternative explanations are considered, but the only tenable explanation of the reduction in mortality is that it is a consequence of the introduction of a comprehensive screening programme.

Adult↗